Search Results for: SRPK2

Novel Interactant Symbol Name
Associated Pathways
Binding Drugs
Associated Diseases
ANK3 ankyrin 3
  • Interaction between L1 and Ankyrins
  • Interaction between L1 and Ankyrins
  • COPI-mediated anterograde transport
ANKFY1 ankyrin repeat and FYVE domain containing 1
ANKRD35 ankyrin repeat domain 35
AP1M1 adaptor related protein complex 1 subunit mu 1
  • Nef mediated downregulation of MHC class I complex cell surface expression
  • MHC class II antigen presentation
  • Lysosome Vesicle Biogenesis
  • Golgi Associated Vesicle Biogenesis
  • Neutrophil degranulation
APEX1 apurinic/apyrimidinic endodeoxyribonuclease 1
  • Displacement of DNA glycosylase by APEX1
  • POLB-Dependent Long Patch Base Excision Repair
  • Resolution of AP sites via the multiple-nucleotide patch replacement pathway
  • PCNA-Dependent Long Patch Base Excision Repair
  • Abasic sugar-phosphate removal via the single-nucleotide replacement pathway
  • Resolution of Abasic Sites (AP sites)
  • Lucanthone
APOBEC3C apolipoprotein B mRNA editing enzyme catalytic subunit 3C
  • mRNA Editing: C to U Conversion
  • Formation of the Editosome
APP amyloid beta precursor protein
  • Platelet degranulation
  • ECM proteoglycans
  • Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)
  • G alpha (q) signalling events
  • G alpha (i) signalling events
  • Lysosome Vesicle Biogenesis
  • Formyl peptide receptors bind formyl peptides and many other ligands
  • TAK1 activates NFkB by phosphorylation and activation of IKKs complex
  • The NLRP3 inflammasome
  • Advanced glycosylation endproduct receptor signaling
  • Advanced glycosylation endproduct receptor signaling
  • Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models
  • Post-translational protein phosphorylation
  • TRAF6 mediated NF-kB activation
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Insertion of tail-anchored proteins into the endoplasmic reticulum membrane
  • Purinergic signaling in leishmaniasis infection
  • Amyloid fiber formation
  • Deferoxamine
  • Aluminium
  • Zinc
  • L-methionine (R)-S-oxide
  • Resveratrol
  • Tromethamine
  • Phenserine
  • Tetrathiomolybdate
  • CAD106
  • Mito-4509
  • Edonerpic
  • Dimercaprol
  • Copper
  • Florbetaben (18F)
  • Florbetapir (18F)
  • Flutemetamol (18F)
  • Zinc acetate
  • Aluminium phosphate
  • Aluminum acetate
  • Zinc chloride
  • Zinc sulfate, unspecified form
  • Alzheimer's disease (AD)
ARFGEF3 ARFGEF family member 3
ARGLU1 arginine and glutamate rich 1
ARHGAP12 Rho GTPase activating protein 12
  • Rho GTPase cycle
ARL6IP4 ADP ribosylation factor like GTPase 6 interacting protein 4
ARPC1B actin related protein 2/3 complex subunit 1B
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • EPHB-mediated forward signaling
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
  • N-[2-(2-methyl-1H-indol-3-yl)ethyl]thiophene-2-carboxamide
  • (2S)-2-(3-bromophenyl)-3-(5-chloro-2-hydroxyphenyl)-1,3-thiazolidin-4-one
ARSG arylsulfatase G
  • Glycosphingolipid metabolism
  • The activation of arylsulfatases
ASL argininosuccinate lyase
  • Urea cycle
  • Arginine
  • Argininosuccinate
  • 2-(N-morpholino)ethanesulfonic acid
  • Argininosuccinic aciduria (ARGINSA); Argininosuccinate lyase deficiency
ATAT1 alpha tubulin acetyltransferase 1
  • Cilium Assembly
AURKA aurora kinase A
  • APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1
  • Regulation of PLK1 Activity at G2/M Transition
  • SUMOylation of DNA replication proteins
  • TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest
  • Regulation of TP53 Activity through Phosphorylation
  • FBXL7 down-regulates AURKA during mitotic entry and in early mitosis
  • AURKA Activation by TPX2
  • Interaction between PHLDA1 and AURKA
  • Phosphonothreonine
  • AT9283
  • CYC116
  • Alisertib
  • SNS-314
  • Cenisertib
  • Enzastaurin
  • 4-(4-METHYLPIPERAZIN-1-YL)-N-[5-(2-THIENYLACETYL)-1,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-YL]BENZAMIDE
  • AKI-001
  • 1-{5-[2-(thieno[3,2-d]pyrimidin-4-ylamino)ethyl]-1,3-thiazol-2-yl}-3-[3-(trifluoromethyl)phenyl]urea
  • 1-(5-{2-[(1-methyl-1H-pyrazolo[4,3-d]pyrimidin-7-yl)amino]ethyl}-1,3-thiazol-2-yl)-3-[3-(trifluoromethyl)phenyl]urea
  • N-{3-[(4-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}PYRIMIDIN-2-YL)AMINO]PHENYL}CYCLOPROPANECARBOXAMIDE
  • N-butyl-3-{[6-(9H-purin-6-ylamino)hexanoyl]amino}benzamide
  • 2-(1H-pyrazol-3-yl)-1H-benzimidazole
  • N-[3-(1H-BENZIMIDAZOL-2-YL)-1H-PYRAZOL-4-YL]BENZAMIDE
  • Fostamatinib
  • MLN8054
BAG3 BAG cochaperone 3
  • Regulation of HSF1-mediated heat shock response
BAIAP2 BAR/IMD domain containing adaptor protein 2
  • Regulation of actin dynamics for phagocytic cup formation
  • Regulation of actin dynamics for phagocytic cup formation
  • VEGFA-VEGFR2 Pathway
  • RHO GTPases Activate WASPs and WAVEs
  • RHO GTPases Activate WASPs and WAVEs
  • FCGR3A-mediated phagocytosis
  • FCGR3A-mediated phagocytosis
BAZ1A bromodomain adjacent to zinc finger domain 1A
BCL9L BCL9 like
  • Formation of the beta-catenin:TCF transactivating complex
  • Deactivation of the beta-catenin transactivating complex

Page 2 out of 22 pages